Phase III Clinical Trial of GD-11 for Injection in the Treatment of Acute Ischemic Stroke

Conditions: Acute Ischemic Stroke Interventions: Drug: GD-11 for injection test group/Placebo control group Sponsors: Beijing Tiantan Hospital; Jiangsu Wangao Pharmaceutical Co. ltd Recruiting

https://clinicaltrials.gov/study/NCT06299579

Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

More News: Clinical Trials | Hospitals | Ischemic Stroke | Research | Stroke